Hogan Lovells lawyers David Horowitz, Heidi Gertner and Sally Gu break down the key aspects of the new legislation | 1yr
Heidi Gertner works at the forefront of the drug regulatory industry. She provides insight to large and small pharmaceutical companies and research institutions in dealing with government regulators to maximize business potential. With her wealth of drug regulatory knowledge and creative thinking skills, Heidi finds solutions to client problems and is a tireless advocate. She helps clients resolve their enforcement differences with the FDA and facilitates positive relationships with the agency. Heidi anticipates and helps clients dealing with cutting-edge issues, both by assessing policy initiatives and finding new business opportunities. She began her professional career with a focus on bioethics and law, completing two post-doctoral bioethics fellowships, one at the Cleveland Clinic Foundation, and another at the National Institutes of Health. At the National Institutes of Health, Heidi's work focused primarily on human subject protection and research ethics issues.
Hogan Lovells lawyers David Horowitz, Heidi Gertner and Sally Gu break down the key aspects of the new legislation | 1yr